News

Video thumbnail with woman looking at a screeeen

Video February 17, 2020

Embracing Disruptive Technologies to Accelerate Science Overcoming Disease

From penicillin to organ transplants, so many important discoveries have dramatically changed healthcare and medicine over the past decades. But what’s really behind all this progress?

Gladstone Experts Research Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab Yamanaka Lab

Katie Pollard, Benoit Bruneau, and Deepak Srivastava

Article January 18, 2020

Gladstone Joins a $5.7 Million Initiative Focused on Single Ventricle Heart Defects

Funds will support five top research institutions to accelerate scientific discoveries and development of treatments for single ventricle heart defects.

Grants News Release Cardiovascular Disease Data Science and Biotechnology Bruneau Lab Pollard Lab Srivastava Lab

UCSF and Gladstone collaborators standing outside the Gladstone building

Article December 13, 2019

$13 Million Grant to Probe the Genome of Heart Cells

Team of six laboratories will combine expertise in heart development and -omics technology to probe genome activity and organization in heart cells.

Grants News Release Heart Failure Bruneau Lab Conklin Lab Krogan Lab Pollard Lab Srivastava Lab

Article December 12, 2019

Gladstone’s Evolution of Research

Gladstone began as a single entity with a single purpose. But as the scientists followed the science—unencumbered by the red tape of bureaucracy—the purpose, and the focus, grew.

History Institutional News Cardiovascular Disease Data Science and Biotechnology Neurological Disease Virology and Immunology Finkbeiner Lab Greene Lab Mahley Lab Mucke Lab

Gladstone President Deepak Srivastava standing on a stage in front of a crowd

Article December 10, 2019

Gladstone Launches Strategic Plan

Gladstone prepares for the future of discovery science with the launch of new strategic plan.

Office of the President History Institutional News Srivastava Lab

Article October 9, 2019

Connecting the Dots: From Stem Cells to Human Health

Since Shinya Yamanaka discovered a method to create human induced pluripotent stem cells (hiPS cells), Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.

Research Finkbeiner Lab Huang Lab McDevitt Lab Srivastava Lab Yamanaka Lab CRISPR/Gene Editing Stem Cells/iPSCs

Article July 30, 2019

Regenerating the Heart after Tissue Damage

Gladstone scientists gain important insights into the cellular reprogramming process

News Release Research Heart Failure Cardiovascular Disease Pollard Lab Srivastava Lab Big Data Stem Cells/iPSCs

Article July 19, 2019

A New Cellular Framework to Study Causes of Birth Defects

Gladstone scientists reveal how gene mutations can alter small groups of cells and result in congenital heart disease

News Release Research Congenital Heart Disease Cardiovascular Disease Srivastava Lab Single Cell

Article July 17, 2019

Meet Gladstone: Yvanka De Soysa

A fan of science since she was a child—and today a Zumba aficionado too—Yvanka would like to meet Albert Einstein’s first wife to warn her about the impact of her marriage on her career.

Office of Postdoctoral and Graduate Affairs Grad Students and Postdocs Profile Cardiovascular Disease Srivastava Lab